River Road Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-203,594
Closed -$34.1M 176
2019
Q2
$34.1M Buy
203,594
+82,377
+68% +$11.4M 0.66% 63
2019
Q1
$17.7M Buy
121,217
+10,436
+9% +$1.51M 0.4% 93
2018
Q4
$14.8M Buy
110,781
+15,616
+16% +$2.56M 0.36% 101
2018
Q3
$18.1M Buy
95,165
+13,126
+16% +$2.41M 0.38% 95
2018
Q2
$13.7M Buy
82,039
+74,714
+1,020% +$12M 0.29% 111
2018
Q1
$1.23M Buy
+7,325
New +$1.23M 0.03% 145
2017
Q2
Sell
-4,672
Closed -$1.12M 158
2017
Q1
$1.12M Sell
4,672
-2,406
-34% -$560K 0.02% 136
2016
Q4
$1.49M Buy
7,078
+2,515
+55% +$521K 0.03% 135
2016
Q3
$1.05M Buy
+4,563
New +$1.12M 0.02% 140

Other funds holding AGN

River Road Asset Management's AGN Position: Q3 2019 in Review

River Road Asset Management sold out of Allergan plc (AGN) in Q3 2019, closing a stake of 203,594 shares — an estimated $34.1M sold.

River Road Asset Management first reported a position in AGN in Q3 2016 and held it in 9 quarters. The position peaked at $34.1M in Q2 2019. 921 funds tracked by Wall St. Rank hold AGN as of Q3 2019.

  • River Road Asset Management reported no remaining Allergan plc position as of Q3 2019 after selling out during the quarter.
  • River Road Asset Management sold 203,594 Allergan plc shares in Q3 2019, an estimated $34.1M.
  • River Road Asset Management first reported a position in Allergan plc in Q3 2016 and held it in 9 quarters.
  • River Road Asset Management's Allergan plc position peaked at $34.1M in Q2 2019.
  • 921 funds tracked by Wall St. Rank held Allergan plc as of Q3 2019.

Based on River Road Asset Management's 13F filing for Q3 2019, filed 5 Nov 2019.